logoblanc
Patients First in Drug Development with Artificial Intelligence

We are thrilled to introduce our monthly newsletter focusing on patient-centered care with an emphasis on AI technology.

As patient involvement continues to play a crucial role in the success of clinical trials and improved medical outcomes, the utilization of AI is essential in managing the wealth of unstructured data collected from patients. ArcaScience, a healthcare startup specializing in AI, has created cutting-edge technology to leverage patient data throughout the drug development process.

Be sure to click and explore the latest editions of our newsletter!

Volume 1
Why this newsletter is so crucial ?
 Explore the content by clicking on the image below.
Capture décran 2024-02-28 152930
Volume 2
Clinical trial & PROMs with AI: the perfect match. 

Explore the content by clicking on the image below.
Vol2

WHY ARCASCIENCE IS UNIQUE ?

ArcaScience is the unique company providing comprehensive Patient Centric data to generate accurate prediction throughout the drug life cycle by using Artificial Intelligence to consolidate original patient-centric datasets helping Healthcare innovators to predict drug efficiency

Patient centric data-1

SINCE 2018, THEY TRUST US: